151 related articles for article (PubMed ID: 30953468)
1. Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor.
Koper-Lenkiewicz OM; Kamińska J; Milewska A; Sawicki K; Jadeszko M; Mariak Z; Reszeć J; Dymicka-Piekarska V; Matowicka-Karna J
BMC Cancer; 2019 Apr; 19(1):319. PubMed ID: 30953468
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid and serum IL-8, CCL2, and ICAM-1 concentrations in astrocytic brain tumor patients.
Koper OM; Kamińska J; Sawicki K; Reszeć J; Rutkowski R; Jadeszko M; Mariak Z; Dymicka-Piekarska V; Kemona H
Ir J Med Sci; 2018 Aug; 187(3):767-775. PubMed ID: 29086194
[TBL] [Abstract][Full Text] [Related]
3. The isoform A of reticulon-4 (Nogo-A) in cerebrospinal fluid of primary brain tumor patients: influencing factors.
Koper OM; Kamińska J; Milewska A; Sawicki K; Mariak Z; Kemona H; Matowicka-Karna J
Oncotarget; 2018 May; 9(38):25048-25056. PubMed ID: 29861852
[TBL] [Abstract][Full Text] [Related]
4. Myelin-associated proteins are potential diagnostic markers in patients with primary brain tumour.
Koper-Lenkiewicz OM; Milewska AJ; Kamińska J; Sawicki K; Chrzanowski R; Zińczuk J; Reszeć J; Tylicka M; Matuszczak E; Matowicka-Karna J; Mariak Z; Mucha MW; Pawlak R; Dymicka-Piekarska V
Ann Med; 2021 Dec; 53(1):1710-1721. PubMed ID: 34601991
[TBL] [Abstract][Full Text] [Related]
5. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
6. Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumour.
Yoshida J; Wakabayashi T; Okamoto S; Kimura S; Washizu K; Kiyosawa K; Mokuno K
J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1212-5. PubMed ID: 7523604
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors.
Peles E; Lidar Z; Simon AJ; Grossman R; Nass D; Ram Z
Neurosurgery; 2004 Sep; 55(3):562-7; discussion 567-8. PubMed ID: 15335423
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Serum Concentrations of Adropin, Afamin, and Neudesin in Children with Type 1 Diabetes.
Polkowska A; Pasierowska IE; Pasławska M; Pawluczuk E; Bossowski A
Biomed Res Int; 2019; 2019():6128410. PubMed ID: 31781629
[TBL] [Abstract][Full Text] [Related]
9. The concentration of alpha-1-antitrypsin in cerebrospinal fluid and serum in a series of 40 intracranial tumors.
Galvez S; Farcas A; Monari M
Clin Chim Acta; 1979 Jan; 91(2):191-6. PubMed ID: 310369
[TBL] [Abstract][Full Text] [Related]
10. Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
Liu J; Zheng S; Yu JK; Zhang JM; Chen Z
J Zhejiang Univ Sci B; 2005 Jan; 6(1):4-10. PubMed ID: 15593384
[TBL] [Abstract][Full Text] [Related]
11. [The diagnostic value of immunoglobulin G in the cerebrospinal fluid of brain tumor patients, particularly in malignant tumors].
Onodera Y; Saitoh Y; Nagai K
Gan No Rinsho; 1987 Oct; 33(12):1402-6. PubMed ID: 3682191
[TBL] [Abstract][Full Text] [Related]
12. Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.
Castellazzi M; Morotti A; Tamborino C; Alessi F; Pilotto S; Baldi E; Caniatti LM; Trentini A; Casetta I; Granieri E; Pugliatti M; Fainardi E; Bellini T
Fluids Barriers CNS; 2020 Feb; 17(1):14. PubMed ID: 32024544
[TBL] [Abstract][Full Text] [Related]
13. Acute or chronic use of lacosamide does not alter its distribution between serum and cerebrospinal fluid.
Michelhaugh SK; Basha M; Rhoney DH; Shah AK; Mittal S
Epilepsia; 2015 Nov; 56(11):1732-7. PubMed ID: 26249845
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
Kopkova A; Sana J; Fadrus P; Slaby O
Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of cisternal cerebrospinal fluid associated with primary brain tumors in the dog: a retrospective study.
Bailey CS; Higgins RJ
J Am Vet Med Assoc; 1986 Feb; 188(4):414-7. PubMed ID: 3949619
[TBL] [Abstract][Full Text] [Related]
16. Myelin basic protein in the cerebrospinal fluid of patients with brain tumors.
Nakagawa H; Yamada M; Kanayama T; Tsuruzono K; Miyawaki Y; Tokiyoshi K; Hagiwara Y; Hayakawa T
Neurosurgery; 1994 May; 34(5):825-33; discussion 833. PubMed ID: 7519757
[TBL] [Abstract][Full Text] [Related]
17. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Friedberg MH; Glantz MJ; Klempner MS; Cole BF; Perides G
Cancer; 1998 Mar; 82(5):923-30. PubMed ID: 9486583
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma.
Sampath P; Weaver CE; Sungarian A; Cortez S; Alderson L; Stopa EG
Cancer Control; 2004; 11(3):174-80. PubMed ID: 15153841
[TBL] [Abstract][Full Text] [Related]
19. Decreased cerebrospinal fluid glutamine levels in patients with benign brain tumors.
el-Yazigi A; Al-Mefty O
J Neurochem; 1985 Sep; 45(3):815-8. PubMed ID: 4031863
[TBL] [Abstract][Full Text] [Related]
20. Neudesin, a novel secreted protein with a unique primary structure and neurotrophic activity.
Kimura I; Yoshioka M; Konishi M; Miyake A; Itoh N
J Neurosci Res; 2005 Feb; 79(3):287-94. PubMed ID: 15605373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
